Condition: Nephropathy · Glomerular Diseases · Idiopathic Membranous Nephropathy · Sponsor: Chinese PLA General Hospital
This is a prospective, multicenter, randomized, open-label, parallel controlled study. The purpose of this study is to evaluate the efficacy and safety of Huaier granule on the treatment of idiopathic membranous nephropathy comparing with Ciclosporin soft capsules.
This description comes directly from the study's public registry record.
Xiangmei Chen, PhD · 00-86-010-66937166 · shengdai26@163.com
Always discuss trial participation with your own doctor first.
| Chinese PLA general hospital | Beijing, Beijing Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05839314